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The psychological impact of prostate cancer
after treatment: a critical review of the literature
Laura Binks1 , Heather Drury-Smith1 and Catherine Holborn1
1College of Health, Wellbeing and Life Sciences, Sheffield Hallam University, Collegiate Crescent, Sheffield, UK
Abstract
Aim: This critical review of the literature seeks to understand the psychological impact that
treatment interventions may have on prostate cancer (PC) survivors.
Materials and Methods: A literature search was conducted using databases of peer-reviewed
literature. The search terms used were devised using the building-blocks technique to divide
the query into facets. The articles were manually assessed for relevance and appraised using
the relevant Critical Appraisal Skills Programme (CASP) tool. Government guidelines and reg-
ulations were also used following a manual search on the National Institute for Health and Care
Excellence (NICE) website. This process resulted in a total of 12 sources being included in the
critical review.
Results: The key themes that arose from the review were masculinity, depression, anxiety and
psychological implications related to sexual functioning. Psychological impact varies on an
individual basis and is influenced by the quality of a patient’s experience during and after treat-
ment in relation to sufficient information giving and support.
Findings: Open communication should be encouraged by healthcare professionals to assess
patient mental wellbeing. The extent of psychological impact varies on an individual basis; how-
ever, there are predictive factors that can make an individual more at risk of being affected
psychologically post-PC treatment.
Introduction
Survivorship is emerging as an area of increased interest within the cancer sciences, with tech-
nological advances continuing to improve cancer survival rates. The importance of supporting
patients’ post-treatment is recognised in national agendas with the NHS AchievingWorld-Class
Cancer Outcomes: A Strategy for England 2015–2020 recognising living with and beyond cancer
as one of their six key points to address to improve care for all patients diagnosed with cancer.1
Prostate cancer (PC) is the fourth most prevalent cancer worldwide with 5-year cancer survival
at 99% in 2009–2015, and therefore this cohort of patients contributes to a large population of
cancer survivors.2
Prostate cancer treatment options are dependent on the stage of the cancer, with the most
common forms of treatment including radical prostatectomy, external beam radiotherapy and
androgen deprivation therapy. Prostate cancer treatment often involves a combination of treat-
ment modalities to control the disease and patients can develop a range of side effects. For exam-
ple, radiotherapy is commonly associated with poorer bowel and urinary incontinence, whereas
radical prostatectomy is commonly associated with sexual dysfunction.3 This was proven from
the research outcomes of the ProtecT trial, which compared side effect outcomes of different
treatments for localised PC.3
As survival rates have increased for PC, this has left survivors facing potential impact upon
their psychological wellbeing. Traditionally, a biomedical model of care is used in the healthcare
setting, rather than a holistic approach to care. The holistic approach supposes that mind and
body are intertwined and should be treated as a whole, which is not the traditional medical view.
There is increasing evidence demonstrating that health and illness are much more complex,
which is illustrated by the biopsychosocial model.4 This has led to wider acknowledgement that
patients whose psychological needs are met cope better with their illness.
Psychological symptoms can range from depression, adjustment disorder and anxiety.5 In
the most severe of cases, patients may suffer from post-traumatic stress disorder (PTSD).5
Other forms of psychological stress can present in the form of guilt, loss of control, anger, con-
fusion, increased vulnerability and fear.6 Side effects associated with PC treatment can also affect
daily living such as continence issues and sexual dysfunction which can lead to relationship
problems.7
It is important to address the topic of understanding the psychological impact upon PC sur-
vivors to analyse how patient’s wellbeing may be affected post-treatment. The long-term physi-
cal side effects of prostate cancer treatments is currently understood; however the underlying
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impact this has on a patients quality of life (QoL) from a psycho-
logical perspective is not as widely understood.
The aim of this critical review is therefore to determine what
impact PC treatments have upon the psychological wellbeing of
patients with PC.
Method
A search of electronic databases for the review including Science
Direct, PubMed and PsychINFO was undertaken using the key
search terms listed in Table 1.
Inclusion and exclusion criteria
Inclusion and exclusion criteria were applied to the articles found,
to focus and determine the final articles for review.
Search strategy
Snowballing was used when papers were found through reference
lists on other articles to ensure other applicable studies were not
missed. This search was conducted from October 2018 to April
2019. The building-blocks technique was used to divide the query
into facets to break up the research question into concept blocks
(Table 2). The author scrutinised the titles, date and abstracts to
identify eligible studies. The PRISMA flowchart was used to dem-
onstrate the search process to improve the reporting of the critical
review (Figure 1).
Articles that met the inclusion and exclusion criteria were
appraised using the appropriate Critical Appraisal Skills Programme
(CASP) checklists relevant to the study design.
Results
In total 18 papers were identified as being eligible for the critical
review, however, only 12 were selected that conveyed the common
3 themes identified; the 6 that were excluded focused on other
psychological impact areas including fear of recurrence, PTSD
and thoughts of suicide, which werementioned less in the literature
and thus this was not deemed a key theme to include in this review.
A summary table can be found in the appendix for the included
studies. The three key themes identified are discussed below:
Discussion
Masculinity
Masculinity can be defined as referring to the behaviours, social
roles and relations of men within a given society as well as the
meanings attributed to them.8 Tsang et al. (2018) study demon-
strated the words patients with PC most associated with masculin-
ity were biologically based and included: sexual ability, sex drive
and/or libido, being physically strong and maintaining bodily
functions.9 This is alike to Chambers et al. (2017), Thomas et al.
(2013) and Zaider et al. (2012) findings of association with the
physical side effects of PC treatment, impacting on men’s percep-
tions of their masculinity.6,7,10. Both Chambers et al. (2017) and
Zaider et al. (2012) recognised the impact of sexual dysfunction
such as erectile dysfunction and loss of libido having the potential
to impact on patients with PC having a lower perception of their
masculinity.6,10 Men who perceive this lower masculinity in
Table 1. A table representation of the critical review’s inclusion and exclusion criteria
Inclusion Exclusion Justification
Research published between 2009 and 2019 Research published prior
to 2009
Only research from 2009 onwards was used to ensure
data were relevant and would recognise any recent
revelations in regards to the psychological impact on
patients who have undergone prostate cancer treat-
ment, and to reflect current treatment practices.
English language Foreign language Only international studies written in English were used
to avoid inaccurate translation and due to the authors’
capabilities.
Prostate cancer patients Non-prostate cancer
patients
Only studies on prostate cancer were used as relevant
to the research question.
Peer-reviewed journals, non-peer-reviewed journals Peer-reviewed
journal articles only were included to ensure reliability of the
review. Localised and locally advanced prostate cancer
Metastatic prostate
cancer
Only studies focused on localised and locally advanced
prostate cancer were used, as the literature recognised
patients with metastatic prostate cancer have different
psychological concerns in relation to prognosis.
Patients who had undergone hormone therapy, radiotherapy,
surgery or combination treatment
Active surveillance All treatment methods were included in the study as
some studies focused on more than one treatment
modality making it a compound task to differentiate




Peer-reviewed journal articles only were included to
ensure reliability of the review.
Table 2. A table showing the main facets behind the research question with
relevant keywords that were used to conduct the literature search to ensure




Prostate cancer, prostate carcinoma, localised
prostate cancer, locally advanced prostate disease,




Psychological implications, quality of life,
psychological impact, psychological features
Post-treatment Post-treatment, after treatment, post-processing,
after treatment, after care
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themselves could be at increased risk of experiencing distress due
to changes in sexual functioning as a result of curative treatment. It
is evident from the literature the importance men place on their
ability to perform sexually to maintain their sense of masculinity,
to the extent of influencing treatment choice because of the like-
lihood of erectile dysfunction post-treatment. Chambers et al.
(2017) and O’Shaunessy et al. (2015) both recognised how some
men chose radiotherapy over radical prostatectomy to preserve
their sexual functioning, with men who did undergo radical
prostatectomy having a deeper fear of sexual dysfunction post-
treatment and thus impacting on patients psychologically.11
Although much of the literature included in this study acknowl-
edges the impact of sexual changes on men’s perceptions of their
masculinity, this may be due to the resulting impact this can have
on the individual’s personal relationships. Both Zaider et al. (2012)
andO’Shaunessy et al. (2015) recognised the impact on adjustment
in survivorship may rely on the quality of intimate relation-
ships.10,11 Zaider et al. (2012) found the association between dimin-
ished masculinity and sexual bother was strongest for men whose
spouses perceived lowmarital affection.10 O’Shaunessy et al. (2015)
addressed how men are conscious of how they are perceived by
those they care about, and that men did not just view sex for pleas-
ure, but as an expression of love for their partners.11 Some men
revealed in the interviews they felt a new appreciation of their rela-
tionships they may have previously taken for granted.11 It could
therefore be beneficial to reduce the threat to masculinity for cli-
nicians to not just focus on improving the physicality of erectile
dysfunction, but a focus around broadening perceptions of sexual
relationships could help patients. Erectile dysfunction interven-
tions should therefore incorporate masculinity in a holistic way
due to masculinity perceptions framing how patients with PC
interpret what is happening to them post-treatment, as suggested
by Chambers et al. (2017).6
Depression and anxiety
It is widely accepted across the literature that patients who have
undergone treatment as a result of a cancer diagnosis are at greater
risk of anxiety and depression, with Van Stam et al. (2017) com-
paring a general population sample of men of similar age with a
Figure 1. PRISMA flowchart demonstrating the data selection process.
Journal of Radiotherapy in Practice 3
. https://doi.org/10.1017/S1460396921000455
Downloaded from https://www.cambridge.org/core. Sheffield Hallam University, on 29 Oct 2021 at 10:17:05, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms
population of PC survivors.12 Fourteen per cent of males had men-
tal health symptoms including anxiety, depression and distress in
the PC survivor group, compared with 6% of the general popula-
tion group. It is evident from the literature that there are a variety
of risk factors that make patients who have undergone radical
treatment to the prostate more at risk of developing psychological
symptoms post-treatment. Albaugh et al. (2017) and Sharp et al.
(2016), both identified anxiety and depression being reported in
patients with sexual dysfunction and decreased sexual activity.13,14
Van Dam, Wassersug and Hamilton (2015) identified that differ-
ent treatment modalities can impact on patients differently, caus-
ing differences in severity of anxiety and depression.15 Although
all patients reported of mood worsening post-treatment in all
modalities studied, those who had received Androgen deprivation
therapy (ADTs) reported of greater negative mood changes.15 This
could be due to the side effects attributed to ADT, such as hot
flushes, gynaecomastia and weight gain, and this interlinks with
the theme of masculinity, and how if this is impacted on, this
can then lead to mental health changes in patients.15 Van Stam
et al. (2017) and Sharp et al. (2016) also recognised the impact
treatment side effects could have on patient’s mental health, and
identified urinary dysfunction post-treatment as a risk factor for
patients to go on to develop anxiety and depression.12,14 Age
was additionally identified as a potential risk factor of anxiety
and depression post-treatment, with younger patients at a height-
ened risk.17 Other risk factors were being widowed, lower educa-
tional levels, lower general health perceptions, bodily pain,
fatigue, insomnia and financial issues.12,14 These potential risk fac-
tors could be used in a predictive table, for side effects and socio-
demographic information to be aware of that may put an
individual more at risk of suffering psychologically post-treatment
(Table 3). Watts et al. (2014) observed that prevalence of anxiety
and depression is evident before treatment, reducing during treat-
ment, before rising again post-treatment, which could be attributed
to reducing during treatment as patients feel supported by health-
care professionals who they are seeing during their treatment.16
Van Stam et al. (2017) and Watts et al. (2014) both recognise if
attention is paid to modifiable factors that have been associated
with increased risk of anxiety and depression, these mental health
problems may be identified earlier and relevant support and treat-
ment can be given.12,16 This could be in the form of an epidemio-
logical investigation to screen for at risk of patients. Furthermore,
treating and managing psychological distress should be a key clini-
cal objective to enhance clinical outcomes and patient QoL. Van
Dam, Wassersug and Hamilton (2015) advise for patients and
partners to be made aware of the psychological implications before
commencing treatments, for patients to be more aware of psycho-
logical side effects so appropriate help can be sought at its earliest
opportunity.15
Psychological impact with sexual functioning
The impact of PC treatments can have on a patient’s sexual func-
tioning is well understood from a biological basis; however, it is
still an area not commonly discussed with patients before, during
or after treatments.7 Analysing the literature revealed common
themes to arise from patients with PC post-treatment regarding
their experiences post-treatment in relation to sexual dysfunction.
The importance of support was highlighted by Thomas et al. (2013)
and Albaugh et al. (2017) with a strong focus on individual support
with tailored advice being imperative to improve patient experi-
ence post-treatment from a psychological perspective.7,13 This sup-
port was suggested to be utilised through support groups, spousal
support groups and understanding from healthcare professionals
to help with the healing process; it is evident from the literature
that men may not actively seek support such as communicating
with their partners or seeking assistance for restoring sexual func-
tion unless it was via more private means such as obtaining Viagra
prescriptions.17 The importance of partners was another theme to
emerge in relation to the psychological impact of sexual function-
ing.7,13,17 The importance of maintaining intimacy did help some
patients post-treatment in regard to their sexual relationships.
Letts, Tamlyn and Byers (2010) conducted a comparison study
comparing questionnaire results pre-PC treatment, which identi-
fied men were engaging regularly in sex and were satisfied in their
relationships, with post-treatment interviews.17 The interviews
revealed most men reporting no change in sexual desire; however,
they were negatively affected in the form of distress due to erection
changes, orgasm consistency and sexual satisfaction. Most men felt
their sex lives were over and some stopped engaging in sexual activ-
ities; it is therefore evident how this could negatively impact on
relationships and thus patient’s psychological wellbeing by remov-
ing an intimate constituent of patient’s personal relationships.
Despite this, men reported of no change in the amount of affection
expressed in their relationships in this study,17; however, Thomas
et al. (2013) identified in their study focusing on gay and bisexual
men with PC, how the majority of participants had no spousal sup-
port.7 Without this form of support, it could be suggested men of
gay or bisexual orientationmay bemore at risk of suffering psycho-
logically post-treatment. Treating patients as individuals in
response to their sexual dysfunction was highlighted across much
of the literature analysed including Hoyt & Carpenter (2015).6,17,18
This is due to the individual being affected differently in each case
in response to changes in their sexual functioning, as well as differ-
ent severities of sexual dysfunction presenting post-treatment. For
example, the level of distress varied depending on the value men
placed on sex or their perceptions of masculinity.18 Sexual-Self
Schema (SSS) was identified as a factor of how much sexual dys-
function affected people depending on their own SSS, with a higher
SSS and poor sexual functioning leading to more depressive
Table 3. A table of potential risk factors of depression and anxiety based on the
critical review findings. This is a general guide. More research is required to prove
this statistically but the table could be used as a guide to help healthcare
professionals identify potential at-risk individuals
Factor Lower risk Higher risk
Age Older age Younger age
Sexuality Heterosexual Homosexual/
bisexual
Marital status Married Single
















in other forms of
sexual expression
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symptoms being observed in these patients.18 Sexual-Self Schema
therefore may be an important difference in determining the
impact of sexual morbidity on psychological adjustment.18
Thomas et al. (2013) highlighted the need for individual support
for gay and bisexual men to tailor support for their needs, as
gay sexual practice often has to alter in response to PC patients
receiving treatment and these patients therefore need individual
care plans.7 A need for accurate information regarding side effects
in relation to sexual functioning is clearly an area requiring devel-
opment as highlighted in the literature.7,13,17 Letts, Tamlyn and
Byers (2010) reported unsatisfactory communication regarding
sexual side effects from physicians, and Thomas et al (2013)
thematic analysis identified a need for information around this
subject, with preparation for treatment side effects being inad-
equate.17,7 Understanding the impact of anticipated side effects
in relation to sexual functioning is imperative to treatment satis-
faction.13 Alongside patient information giving, the sensitivity of
healthcare professionals is key, in addition to when clinicians
are helping patients with erectile dysfunction to broaden patient
perceptions of sexual relationships as a way to help patients feel
more supported.13,17
Conclusion
The results from this critical review illustrate the complexity of the
psychological impact that treatments can have on PC survivors.
The current treatments available for PC are advanced and impres-
sive, but with such remarkable survival rates and prevalence, one
must step back to evaluate the QoL in survivors. The physical side
effects of PC treatment correlate strongly with the potential for a
significant psychological impact in terms of altering self-image in
relation to masculinity, depression and anxiety and psychosocial
impact related to sexual functioning changes. Current research
such as the ProtecT trial found differences in the side effects of
radical prostatectomy in comparison with radiotherapy, with
men undergoing surgery more likely to experience problems with
sexual function and urinary incontinence, with men undergoing
radiotherapy also having sexual functioning problems and bowel
incontinence.5 A future comparative study including ADTs should
be conducted to help with patient treatment decision-making, and
to tailor future information and advice for patients depending on
the treatment chosen.
Throughout the literature, patients commented on how they
would have felt better prepared for side effect presence if they
had been given more comprehensive, tailored information and
support. Sexual functioning side effects were commonly reported
to have not been explained in a thorough manner, with limited
information provided to patients. Appropriate information giving
is therefore fundamental to ease the psychological burden of sexual
dysfunction which can, in turn, lead tomen’s changing perceptions
of their masculinity, and lead to anxiety and depression. A sugges-
tion could be for oncologists and healthcare professionals to take a
more comprehensive information giving approach, as well as being
open and honest when discussing sexual functioning changes post-
treatment. Encouraging openness can also find out more from an
individual, and as identified in the literature, the severity of
psychological impact on patients vary from individual to individ-
ual, and an individually-tailored care plan would best support
patients post-treatment. The treatment consent process could also
inform patients of the heightened risk of psychological conditions
developing as a result of the physical side effects that can persist
post-treatment, so support can be accessed at a patient’s earliest
opportunity, as well as raising awareness of the normality of
experiencing such psychological changes such as anxiety and
depression post-treatment.
Prostate cancer patients are more at risk of anxiety and depres-
sion than men of similar age, but it would be wrong to assume all
PC patients will suffer from psychological symptoms. Although
psychological changes were reported in all studies, not all survivors
were negatively impacted by PC and treatment. Some patients had
the ability to turn their journey into a positive experience, and
much could be learned from these men to help others who may
struggle post-treatment. It would be beneficial to do a form of
qualitative research on this cohort such as a focus group to identify
coping mechanisms or access to support to better understand how
healthcare professionals can help support those who may be strug-
gling. Future studies must investigate the exact prevalence of
patients affected psychologically by treatment to fully understand
the severity of these psychological side effects and to potentially
reframe national agendas to ensure patients are fully supported.
Some of the literature interpreted their results as being potential
predictors of those who may be most probable to suffer from
depression and anxiety following treatment. A large comparative
study of patient-reported outcomes would help reveal if different
treatment modalities had differing psychological impacts to iden-
tify a treatment modality thatmakes survivors more at risk. Having
predictors would give healthcare professionals an awareness to
ensure patients have support in place to help manage potential
psychological changes. Based on the studies reviewed, a checklist
could be created to help identify at-risk individuals based on the
summary of results included in Table 3.
The need for treating all patients as individuals has previously
been highlighted, due to differing sociodemographic data and dif-
ferent treatment side effects and severity, this can impact on
patients psychologically differently. The feasibility of assessing
the psychological impact of all PC survivors is not realistic due to
the overstretched NHS for budget and resources, thereby utilising
the research, predictors of at-risk individuals are more representa-
tive to target specific PC survivors. Risk checklists could be a forma-
tive way to assess patients before they start treatment to highlight
those at risk based on sociodemographic data, and post-treatment
questionnaires should be used to assess side effect presence and
severity; patients highlighted as at risk in each of these groups should
be directed to relevant support. Support can take different forms,
and with PC patients, it is important more research is conducted
to see which support patients would most utilise, or a range of sup-
port options should be available to suit the individual.
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PC who had under-
gone treatment in
the last 1–5 years



































• Prostate cancer survi-
vors experience with
SD post-treatment
• Prostate cancer survi-
vors’ partners experi-
ence with SD post-
treatment
Themes identified were frus-
tration with sexual dysfunction,
importance of support and
understanding from others,
depression and anxiety related
to sexual dysfunction, impor-
tance of intimacy with partner,
factors that impact treatment
satisfaction, and education and
comprehensive information
about sex.
• Prostate cancer survivors
and their partners have a
need for accurate informa-
tion regarding side effects
before, during and after
treatment
• Prostate cancer survivors
and their partners want
providers to be sensitive to
their sexuality and assist in
finding appropriate help
• Men with SD report of frus-
tration, depression and
anxiety
• Support and understanding
from partners and support
groups important part of
the healing process
• Understanding the impact
of anticipated side effects















with RP, 23% RT,
23% HT, 9% unre-
ported. Time since
treatment ranging

















• Or where masculinity
emerged as a theme
• Psychological or QoL
outcomes
Seventeen per cent reported on
ED scores from validated mea-
surements. Masculinity score
measurements study specific. ED
and loss of libido was consis-
tently described as impacting on
men’s masculinity post-treat-
ment. Some men chose to
undergo RT as opposed to RP to
preserve sexual function which
in their view was equivalent to
masculinity. The majority of
studies identified masculinity
was lost or diminished. Some
qualitative studies described
masculinity as framing men’s
experiences and adjustment
post-treatment.
• Clinicians can help patients
with ED broaden their per-
ceptions of sexual relation-
ships and make meaning
of their experiences to
decrease threat to mascu-
linity
• Interventions for ED should
incorporate masculinity in
a holistic way
• Masculinity frames how
men interpret what is hap-
pening to them
• Men’s self of themselves
and their masculinity suf-







localised PC 2 years
post-treatment with
either RP or RT. n
= 66. Assessed T1 (2






(SSS) Scale for Men,
Sexual Experience
Scale and EPIC.
Overall aim to evalu-










No significant effect of SSS on
depressive symptoms at T1;
however, better sexual function-
ing was related to fewer depres-
sive symptoms (B = −.25, p< 0
05). Results showed significant
interactions between SSS and
sexual outcomes. Among men
with high SSS, poor sexual func-
tioning was associated with
increased depressive symptoms;
loss of sexual function was par-
ticularly distressing. There was
no significant effect of sexual
functioning. Among men with
high SSS, there was an inverse
relationship between sexual
engagement and depressive
symptoms. Among men with
lower SSS, greater frequency of
sexual behaviour was associated
with increased depressive
symptom
• Sexual-Self Schema may
be an important individual
difference in determining
the impact of sexual mor-
bidity on psychological
adjustment.
• Men high on SSS are more
vulnerable to psychological
consequences of lower sex-
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treated with PC. n
= 19. Ten men
received RT, nine
RP. Average 2 ½
years post-treat-






















• Impact of post-treat-
ment sexual changes
• Moderating factors of
sexual functioning
Not all aspects of sexual well-
being are affected by treat-
ments, and specific aspects and
emotional impact varied on an
individual basis. Majority
reported prior to treatment to
be engaging in regular sexual
activity and satisfied with their
relationship. Post-treatment,
majority reported no change in
amount and type of affection
expressed, their sexual desire,
their masculinity concept or
quality of their relationship.
However, majority of men
described negative changes
which caused distress including
erection changes, orgasm con-
sistency and sexual satisfaction.
Most men believed their sex life
was over and some stopped
engaging in sexual activity.
• Majority of men experience
distress due to sexual
changes as a result of
treatment
• The level of distress experi-
enced is dependent on the
value placed on sex and
men’s perceptions of mas-
culinity
• Men did not converse with
their partners regarding
their emotions or seek
assistance in restoring sex-
ual function except for
Viagra








treated for PC and
their partners. n= 30
men and partners.



















from results of pre-
vious study and lit-
erature search.
Outcomes measured:




Four key themes identified in
love: romantic love, compassion-
ate love, expressing love through
sex and coping with lovemaking
changes. Importance of passion
and sexuality in relationships
recognised by both men and
partners. Men did not view sex
as just for pleasure, but rather a
key language to express love to
partners. There is a deeper fear
associated with men undergoing
RP.




• Challenges of the cancer
pathway either benefitted
men and their partners
strengthening relationships
or exposed cracks in men’s
resilience and relationships
• Men are conscious of how
they are perceived by
those they care about
• Common theme from the
interviews was most men
felt they had a new appre-
ciation of their relation-
ships they may have
previously taken for
granted
• Men described hope as
dynamic and linked to vul-
nerability of disease pro-
gression, treatment side








































Fifty-four per cent response rate.
Ninety one per cent included in
analysis. Seventeen per cent
scored for depression. Sixteen
per cent scored for anxiety.
Eleven per cent scored for dis-
tress. Depression was lower in
older men and educated men,
and higher in unmarried men
and unemployed. Risk of depres-
sion, anxiety and distress was
higher in men who had treat-
ment for depression.
Comorbidities was associated
with increased risk of anxiety.
Risk of depression was higher in
men with higher urinary and
ADT-related symptoms, and
fatigue, insomnia and financial
issues. Higher sexual activity
reduced risk of depression, anxi-
ety and distress.
• Higher symptom scores
positively correlated with a
higher risk of poor psycho-
logical wellbeing.
• Cancer-related symptoms





• There is significant overlap
of survivors demonstrating
two or more psychological
wellbeing measurements
• PC-specific symptoms of








• Increased sexual activity
was associated with lower
risk of psychological well-
being
(Continued)
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identifying as gay or
bisexual diagnosed
with PC within 7
years. Participants
must be able to
read in English.
Previous treatment
was not essential. n
= 10. Seven RP, two

























• Accessing help and
support
• Impact of incontinence
• Impact of sexual
changes and identity
• Changed sexual rela-
tionships
• Emotional state moder-
ated by the ability to
re-evaluate life
• Changed sexual rela-
tionships
• Finding the right
healthcare professional
• Current needs to
improve quality of care
• Online focus group
experience
Thematic analysis identified a
variety of emotional responses
including shock and disbelief,
the need to confront mortality
and a need for information.
Three participants felt a tailored
support group would be benefi-
cial. Three participants identified
an inner strength as a result of
challenging PC diagnosis. One
participant struggled with nor-
mal social interaction and daily
routine due to incontinence,
with regret over undertaking
treatment. Majority of patients
experience of sexual changes
impacted masculine perception
of themselves. Altered gay sex-
ual practice was identified as a
common issue.
• Psychological impact may
be significant over an
extended time-frame
• A sense of regret was occa-
sionally identified over
treatment choice when fail-
ing to meet expectations
• Participants may have felt
less supported as a major-
ity did not have spousal
support
• Preparation for treatment
side effects was inad-
equate
• A need to tailor advice for
gay/bisexual men may help
patients feel supported, in
particular to sexual func-
tioning support












HT. n= 810 collec-


























• Frequency of masculin-
ity terms
• Biological feature or
social norm recorded







Forty per cent reported changes
in men’s perceptions of mascu-
linity as a result of PC treat-
ment. The four most commonly
used terms by patients, all of
which appeared in six or more
separate studies, were as fol-
lows, in descending order: sex-
ual ability, sex drive and/or
libido, being physically strong
and maintaining control of
bodily functions. Terms used by
researchers to characterise mas-
culinity not explicitly reported
by patients in descending order,
the three most frequently used
terms were as follows: self-reli-
ant/independent, sexual ability
and stoicism
• Loss of masculinity is
largely experienced biologi-





improving QoL in PC
patients
• There were notable
differences between what
patients perceived as a
decline in their masculinity
when spontaneously self-
reported, and when elic-
ited through pre-existing
measures
• Patients most often












and treated and PC
patients’ partners.
PC patients n= 295,
82 ADT, 213 non-
ADT. Partners n= 84,






















the Profile of Mood
States. Comparison








• Patient’s current mood





• Comparison of out-
comes of ADT treat-
ment versus other PC
treatments
POM’s scores for ADT patients
and non-ADT patients entered
into ANOVA showing a signifi-
cant effect in age. Men on ADT
reported worsened fatigue and
lower scores of vigour. No sig-
nificant difference on treatment
for depression, tension, anger or
confusion. Partners of men with
PC regardless of treatment, POM
scores showed a similar pattern.
Both PC patient groups reported
worsening mood since having
treatment but men on ADT
reported greater increases in
negative mood and decreases in
positive mood.
• ADT impacts on PC survi-
vor’s mood more signifi-
cantly than other PC
treatments
• Mood is affected more so
in younger patients
• Prostate cancer partners
verify patient mood
changes but view this con-
currently
• ADT psychological changes
can impact on relation-
ships and QoL for both sur-
vivors and partners
• Patients and partners are
likely to benefit from being
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• Time since diagnosis
• Health-related QoL
• MH
Clinically relevant MH symptoms
observed in 14% of PC survivors
and 6% GenPop control. Being
widowed, lower educational lev-
els, lower general health percep-
tions, bodily pain, urinary bother
and less sexual satisfaction was
the most important correlates of
lower MH scores in PC survivors.
Lower general health percep-
tions, role limitations due to
physical problems and bodily
pain correlated with lower MH
scores in the GenPop.
• Long-term PC survivors
have poorer MH outcomes
than men in an age-
matched population
• Attention to modifiable
factors associated with MH
problems may help to pre-






















































• Number of studies
reporting depression
• Number of studies
reporting anxiety
• Number of patients
measured for depres-
sion






Depression and anxiety preva-
lence are highest in patients
who have yet to undergo
treatment (17·27% and 27·4%,
respectively), lowest in
patients who currently under-
taking treatment (14·7% and
15·9%) before rising again in
patients completed treatment
(18·44% and 18·49%).
Prevalence of clinical depression
and anxiety in British men
>65years is estimated to be
less than 9% and 6%, respec-
tively, in contrast to the
prevalence reported in
patients with PC of the same
age.
• Prevalence of anxiety and
depression in PC is high
across all treatment stages
• Additional epidemiological
investigation is required to
offer a more risk adapted
approach with more inten-
sive screening and support
being offered to individuals





and management of con-
current psychological dis-
tress should be a key
clinical objective as a
means of enhancing clini-




n= 75. Men with
localised PC in the
past year were




RT or RP. Men must
be married or living



















• Men’s adaption to ED
• Loss of masculinity
post-treatment
Approximately one-third of men
felt they had lost a dimension of
their masculinity following treat-
ment. Diminished masculinity
was the only significant, inde-
pendent predictor of sexual
bother, even after accounting
for sexual functioning status.
The association between dimin-
ished masculinity and sexual
bother was strongest for men
whose spouses perceived low
marital affection.
• Diminished masculinity is
prominent but understud-
ied in PC survivors
• Men who perceive LoM
may be more likely to
experience distress
because of their ED
• Impact on adjustment in
survivorship may rely on
quality of intimate
relationships
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